Evidence map›Paper›PMID 30920199›Full record

ArticleACS infectious diseases2019

Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.

Pengfei Wang, Đani Škalamera, Xianwei Sui, Ping Zhang, Suzanne M Michalek

Abstract readEvaluation Study
In one paragraph

Article in ACS infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Development of semisynthetic saponin immunostimulants.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2024
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Structural Effect on Adjuvanticity of Saponins.Journal of medicinal chemistry · 2020
    Article
  11. Vaccine Adjuvants Derivatized fromJournal of medicinal chemistry · 2019
    Article
  12. Effects of Wild Yam Root (Cancer genomics & proteomics
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Đani Škalamera
Xianwei Sui
Ping Zhang
Suzanne M Michalek

Funding

Development of Structurally Defined Synthetic Vaccine Adjuvants-equip supR01GM120159 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WANG, PENGFEI · 2017 to 2020
$1.2M
Development of Structurally Defined QS-17/18-Based Vaccine AdjuvantsR21AI121586 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WANG, PENGFEI · 2016 to 2017
$397k
DESIGN AND SYNTHESIS OF STRUCTURALLY DEFINED QS-21-BASED SYNTHETIC ADJUVANTSR03AI099407 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WANG, PENGFEI · 2012 to 2013
$147k
NIAID NIH HHS R03 AI099407NIAID NIH HHS R21 AI121586NIGMS NIH HHS R01 GM120159
6 · The paper itself

Abstract

We have designed and synthesized two analogs (5 and 6) of QS-7, a natural saponin compound isolated from Quillaja saponaria (QS) Molina tree bark. The only structural difference between compound 5 and 6 is that 5 is acetylated at the 3- and 4-O positions of the quillaic acid C28 fucosyl unit while 6 is not. However, the two analogs show significantly different immunostimulant profiles. Compound 5 may potentiate a mixed Th1/Th2 (Th, T helper cells) immune response against the specific antigens while compound 6 may only induce a Th2-biased immunity. These results suggest that the 3- and/or 4-O acetyl groups of the fucosyl unit may play an important role in tuning the adjuvanticity of the QS-7 analogs, and compound 5 can serve as a structurally defined synthetic adjuvant when a mixed Th1/Th2 immune responses is desired.

Indexed as

Antibody FormationAdjuvants, ImmunologicAnimalsAntigens, BacterialFemaleImmunoglobulin GMice, Inbred BALB CQuillajaSaponinsAdjuvants, ImmunologicAntigens, BacterialImmunoglobulin GQS 7SaponinsadjuvantimmunostimulantQS-7saponinvaccine

Identifiers

PMID30920199
PMCPMC6848976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.